U.S. flag

An official website of the United States government

NM_000546.6(TP53):c.847C>T (p.Arg283Cys) AND Malignant tumor of breast

Germline classification:
Uncertain significance (1 submission)
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001357872.9

Allele description [Variation Report for NM_000546.6(TP53):c.847C>T (p.Arg283Cys)]

NM_000546.6(TP53):c.847C>T (p.Arg283Cys)

Gene:
TP53:tumor protein p53 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17p13.1
Genomic location:
Preferred name:
NM_000546.6(TP53):c.847C>T (p.Arg283Cys)
Other names:
p.R283C:CGC>TGC
HGVS:
  • NC_000017.11:g.7673773G>A
  • NG_017013.2:g.18778C>T
  • NM_000546.6:c.847C>TMANE SELECT
  • NM_001126112.3:c.847C>T
  • NM_001126113.3:c.847C>T
  • NM_001126114.3:c.847C>T
  • NM_001126115.2:c.451C>T
  • NM_001126116.2:c.451C>T
  • NM_001126117.2:c.451C>T
  • NM_001126118.2:c.730C>T
  • NM_001276695.3:c.730C>T
  • NM_001276696.3:c.730C>T
  • NM_001276697.3:c.370C>T
  • NM_001276698.3:c.370C>T
  • NM_001276699.3:c.370C>T
  • NM_001276760.3:c.730C>T
  • NM_001276761.3:c.730C>T
  • NP_000537.3:p.Arg283Cys
  • NP_000537.3:p.Arg283Cys
  • NP_001119584.1:p.Arg283Cys
  • NP_001119584.1:p.Arg283Cys
  • NP_001119585.1:p.Arg283Cys
  • NP_001119586.1:p.Arg283Cys
  • NP_001119586.1:p.Arg283Cys
  • NP_001119587.1:p.Arg151Cys
  • NP_001119588.1:p.Arg151Cys
  • NP_001119589.1:p.Arg151Cys
  • NP_001119590.1:p.Arg244Cys
  • NP_001263624.1:p.Arg244Cys
  • NP_001263625.1:p.Arg244Cys
  • NP_001263626.1:p.Arg124Cys
  • NP_001263627.1:p.Arg124Cys
  • NP_001263628.1:p.Arg124Cys
  • NP_001263689.1:p.Arg244Cys
  • NP_001263690.1:p.Arg244Cys
  • LRG_321t1:c.847C>T
  • LRG_321t2:c.847C>T
  • LRG_321t3:c.847C>T
  • LRG_321:g.18778C>T
  • LRG_321:p.Arg283Cys
  • LRG_321p1:p.Arg283Cys
  • LRG_321p3:p.Arg283Cys
  • NC_000017.10:g.7577091G>A
  • NM_000546.4:c.847C>T
  • NM_000546.5(TP53):c.847C>T
  • NM_000546.5:c.847C>T
  • NM_001126112.2:c.847C>T
  • NM_001126114.2:c.847C>T
  • P04637:p.Arg283Cys
  • p.R283C
Protein change:
R124C
Links:
UniProtKB: P04637#VAR_006017; dbSNP: rs149633775
NCBI 1000 Genomes Browser:
rs149633775
Molecular consequence:
  • NM_000546.6:c.847C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126112.3:c.847C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126113.3:c.847C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126114.3:c.847C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126115.2:c.451C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126116.2:c.451C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126117.2:c.451C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126118.2:c.730C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276695.3:c.730C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276696.3:c.730C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276697.3:c.370C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276698.3:c.370C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276699.3:c.370C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276760.3:c.730C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276761.3:c.730C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Malignant tumor of breast
Synonyms:
Malignant breast neoplasm; Cancer breast
Identifiers:
MONDO: MONDO:0007254; MedGen: C0006142

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV001553463Department of Pathology and Laboratory Medicine, Sinai Health System - The Canadian Open Genetics Repository (COGR)

See additional submitters

no assertion criteria provided
Uncertain significanceunknownclinical testing

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Department of Pathology and Laboratory Medicine, Sinai Health System - The Canadian Open Genetics Repository (COGR), SCV001553463.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The TP53 p.Arg283Cys variant was identified in 14 of 16242 proband chromosomes (frequency: 0.0009) from individuals or families with gastric cancer, breast cancer, leiomyosarcoma, sarcoma, or colorectal cancer and was present in 2 of 23844 control chromosomes (frequency: 0.00008) from healthy individuals (Keller 2004, Manoukian 2007, Mitchell 2013, Momozawa 2018, Yurgelun 2015). The variant was also identified in dbSNP (ID: rs149633775) as "With Likely pathogenic allele", ClinVar (classified as likely benign by one submitter; as uncertain significance by Invitae, GeneDx, Ambry Genetics and six other submitters; and as likely pathogenic by one submitter), Cosmic (22x in breast, endometrium, pancreatic and other tissues ), and LOVD 3.0 (3x). The variant was identified in control databases in 24 of 277184 chromosomes at a frequency of 0.00009 (Genome Aggregation Database Feb 27, 2017). The frequency of the variant in certain populations increases the likelihood that this is a low frequency, benign variant; it was observed in the following populations: African in 3 of 24034 chromosomes (freq: 0.0001), Other in 1 of 6466 chromosomes (freq: 0.0002), and European in 20 of 126682 chromosomes (freq: 0.0002), while the variant was not observed in the Latino, Ashkenazi Jewish, East Asian, Finnish, or South Asian populations. In vitro studies of the variant provide conflicting data: the variant demonstrated weakly temperature-dependent activity, partial deficiency of activity, or activity similar to wild type (Jagosove 2012, Pekova 2011, Monti 2011). The variant was identified in a family meeting criteria for HBOC and Li Fraumeni-like syndrome along with a pathogenic BRCA2 variant (c.7408A>T, p.R2394X). The p.Arg283 residue is conserved in mammals but not in more distantly related organisms, and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) suggest that the variant may impact the protein; however, this information is not predictive enough to assume pathogenicity. The variant occurs outside of the splicing consensus sequence and 1 of 4 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) predicts a greater than 10% difference in splicing. In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 9, 2024